Food allergy is one of the significant types of allergy. Food allergies can be brought about by dairy animals’ milk, shellfish, eggs, and numerous different types of foods, including peanuts. However, peanut hypersensitivity is extremely predominant in the present situation, particularly in kids. The most hazardous of these reactions is an acute systemic reaction called anaphylaxis.
No proper vaccine available for the treatment of peanut allergy, only some experimental medicines are utilized for treating peanut allergy.
Internationally, the occurrence of peanut allergy is expanding upheld by the rising birth rates. The market is additionally determined by expanding awareness about the treatment, rapid adoption, advancements in technology, and increasing demand from developing economies. With an ever-increasing number of organizations teaming up with emergency clinics and autonomous research focuses to grow new and imaginative treatment techniques will help to grow the peanut market globally.
The global Peanut Allergy Vaccine market is segregated on the basis of Type as AR101, ASP0892, and Others. Based on End-User Industry the global Peanut Allergy Vaccine market is segmented in Personal Clinics, Hospitals, Government Agencies, Medical Practitioners, and Others.
The global Peanut Allergy Vaccine market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Peanut Allergy Vaccine market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Aimmune Therapeutics, DBV Technologies, Prota Therapeutics, Cambridge Allergy, Sanofi, Aravax, AnaptysBio, Astellas Pharma, Immunomic Therapeutics, HAL Allergy, and others are among the major players in the global Peanut Allergy Vaccine market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Peanut Allergy Vaccine Market has been segmented as below:
Peanut Allergy Vaccine Market, By Type
Peanut Allergy Vaccine Market, By End-User Industry
Peanut Allergy Vaccine Market, By Region
Peanut Allergy Vaccine Market, By Company
The report covers:
Report Scope:
The global Peanut Allergy Vaccine market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Peanut Allergy Vaccine market share. Major industry players with significant revenue share include Aimmune Therapeutics, DBV Technologies, Prota Therapeutics, Cambridge Allergy, Sanofi, Aravax, AnaptysBio, Astellas Pharma, Immunomic Therapeutics, HAL Allergy, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1. Key Take Aways
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
5. Peanut Allergy Vaccine Market, By End User
5.1. Key Points
5.2. Hospitals
5.3. Medical Practitioners
5.4. Government Agencies
5.5. Personal Clinics
5.6. Others
6 Peanut Allergy Vaccine Market, By Type
6.1 AR101
6.2 ASP0892
7. Peanut Allergy Vaccine Market, By Region
7.1. Key Points
7.2. North America
7.2.1. U.S
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. U.K
7.3.3. France
7.3.4. Italy
7.3.5. Spain
7.3.6. Netherlands
7.3.7. Belgium
7.3.8. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. Australia
7.4.5. Rest of Asia Pacific
7.5. Rest of World
7.6. Competitive Landscape
7.7. Introduction
7.8. Recent Developments
7.8.1. Mergers & Acquisitions
7.8.2. New Product Developments
7.8.3. Portfolio/Production Capacity Expansions
7.8.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.8.5. Others
8. Company Profile
8.1. Allergy Therapeutics
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Zicam
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. Aravax
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. Immunomic Therapeutic
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Astellas
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Aimmune.
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
The Peanut Allergy Vaccine Market has been segmented as below:
Peanut Allergy Vaccine Market, By Type
Peanut Allergy Vaccine Market, By End-User Industry
Peanut Allergy Vaccine Market, By Region
Peanut Allergy Vaccine Market, By Company
